XML 59 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Additional Information (Detail)
9 Months Ended
Sep. 30, 2018
USD ($)
ft²
Aug. 10, 2018
ft²
Dec. 08, 2016
USD ($)
May 20, 2016
USD ($)
Commitments And Contingencies Disclosure [Line Items]        
Operating lease expiration date 2018-02      
South San Francisco, California | New Office Lease Agreement        
Commitments And Contingencies Disclosure [Line Items]        
Leased area | ft² 8,606      
Operating lease term of contract 5 years 2 months      
Operating lease commencement date Feb. 16, 2018      
South San Francisco, California | Office Lease Agreement        
Commitments And Contingencies Disclosure [Line Items]        
Leased area | ft²   4,626    
Pfizer Inc | Collaboration Agreement        
Commitments And Contingencies Disclosure [Line Items]        
Milestone payment $ 1,000,000      
Pfizer Inc | Collaboration Agreement | Maximum        
Commitments And Contingencies Disclosure [Line Items]        
Contingent cash payments upon achievement of clinical, regulatory and commercial milestones     $ 17,500,000  
AGC Biologics, Inc | MarzAA        
Commitments And Contingencies Disclosure [Line Items]        
Contractual obligation payments 300,000     $ 3,800,000
Accrued liabilities 300,000      
AGC Biologics, Inc | Dalcinonacog alfa (“DalcA”)        
Commitments And Contingencies Disclosure [Line Items]        
Contractual obligation payments $ 3,900,000     $ 5,600,000